NRx Pharmaceuticals receives FDA bioequivalence determination for ketamine

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to NRx Pharmaceuticals receives FDA bioequivalence determination for ketamine
(NASDAQ: NRXP) Delayed: 3.76 -0.14 (3.59%)
Previous Close $3.90    52 Week High $ 
Open $3.80    52 Week Low $ 
Day High $3.93    P/E N/A 
Day Low $3.72    EPS $ 
Volume 800,233